Novartis announced plans to eliminate around 680 jobs in its project development sector over the next two to three years. Around 440 of the positions are based in Switzerland with another 240 in the U.S.
The layoffs are part of a global restructuring initiative that began in 2022. The plan could affect up to 8,000 worldwide, according to Swiss news source Tages-Anzeiger.
https://www.biospace.com/article/the-6-largest-biopharma-layoffs-of-2024-so-far/